Ian Stansfield

1.0k citations

23 papers · 745 indexed · h-index 15

Co-authors: Michael Rowley Frank Narjes Nadia Gennari Immacolata Conte Giovanni Migliaccio Paul D. Leeson Graeme I. Stevenson Uwe Koch
Topics: Hepatitis C virus research (9 papers)Protein Kinase Regulation and GTPase Signaling (6 papers)Biochemical and Molecular Research (5 papers)
Cited by: Hepatology Infectious Diseases Organic Chemistry
Journals: Journal of Virology Journal of Medicinal Chemistry Bioorganic & Medicinal Chemistry Letters
Partner nations: United Kingdom Italy United States

In The Last Decade

Ian Stansfield

23 papers receiving 689 citations

Peers

Countries citing papers authored by Ian Stansfield

Since Specialization

Citations

This map shows the geographic impact of Ian Stansfield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian Stansfield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian Stansfield more than expected).

Fields of papers citing papers by Ian Stansfield

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian Stansfield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian Stansfield. The network helps show where Ian Stansfield may publish in the future.

Co-authorship network of co-authors of Ian Stansfield

This figure shows the co-authorship network connecting the top 25 collaborators of Ian Stansfield. A scholar is included among the top collaborators of Ian Stansfield based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian Stansfield. Ian Stansfield is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The identification of a selective dopamine D2 partial agonist, D3 antagonist displaying high levels of brain exposure 2010 ·Bioorganic & Medicinal Chemistry Letters ·Ian P. Holmes,(unknown),Olivier Lorthioir,(unknown),(unknown),Andrew H. Payne,Ian Stansfield,Martyn Wood,P.M. Woollard,Charlie Reavill,(unknown),Fabrizio Micheli,Romano Di Fabio,Daniele Donati,Silvia Terreni,Dieter Hamprecht,Luca Arista,Angela Worby,Steve P. Watson	5
2	Synthesis and SAR of piperazinyl-N-phenylbenzamides as inhibitors of hepatitis C virus RNA replication in cell culture 2009 ·Bioorganic & Medicinal Chemistry Letters ·Immacolata Conte,Claudio Giuliano,(unknown),Frank Narjes,Uwe Koch,Michael Rowley,Sergio Altamura,Raffaele De Francesco,Petra Neddermann,Giovanni Migliaccio,Ian Stansfield	26
3	Tetracyclic indole inhibitors of hepatitis C virus NS5B-polymerase 2008 ·Bioorganic & Medicinal Chemistry Letters ·Ian Stansfield,(unknown),Angela Mackay,Immacolata Conte,(unknown),Uwe Koch,Nadia Gennari,Claudio Giuliano,Michael Rowley,Frank Narjes	38
4	Development of carboxylic acid replacements in indole-N-acetamide inhibitors of hepatitis C virus NS5B polymerase 2007 ·Bioorganic & Medicinal Chemistry Letters ·Ian Stansfield,(unknown),Immacolata Conte,(unknown),Giovanni Migliaccio,(unknown),Claudio Giuliano,Michael Rowley,Frank Narjes	25
5	Identification of thieno[3,2-b]pyrroles as allosteric inhibitors of hepatitis C virus NS5B polymerase 2006 ·Bioorganic & Medicinal Chemistry Letters ·Jesus M. Ontoria,José Ignacio Martı́n Hernando,Savina Malancona,(unknown),Ian Stansfield,Immacolata Conte,(unknown),Jörg Habermann,(unknown),Marcello Di Filippo,Uwe Koch,Michael Rowley,Frank Narjes	33
6	Phenyldihydroxypyrimidines as HCV NS5B RNA Dependent RNA Polymerase Inhibitors. Part II: Sulfonamides 2005 ·Letters in Drug Design & Discovery ·(unknown),Claudio Giuliano,Monica Donghi,(unknown),Victor G. Matassa,Ian Stansfield	3
7	SAR and pharmacokinetic studies on phenethylamide inhibitors of the hepatitis C virus NS3/NS4A serine protease 2004 ·Bioorganic & Medicinal Chemistry Letters ·Savina Malancona,Stefania Colarusso,Jesus M. Ontoria,(unknown),(unknown),Ian Stansfield,Ralph Laufer,Annalise Di Marco,Marina Taliani,(unknown),(unknown),Victor G. Matassa,Frank Narjes	20
8	Active site inhibitors of HCV NS5B polymerase. The development and pharmacophore of 2-thienyl-5,6-dihydroxypyrimidine-4-carboxylic acid 2004 ·Bioorganic & Medicinal Chemistry Letters ·Ian Stansfield,(unknown),Stefania Colarusso,Nadia Gennari,Frank Narjes,Barbara Pacini,(unknown),Steven J. Harper	31
9	The identification of clinical candidate SB-480848: a potent inhibitor of lipoprotein-associated phospholipase A2 2003 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Jackie C. Bloomer,Murray J. B. Brown,Hung‐Yuan Cheng,Beverley Hammond,Deirdre M. B. Hickey,Robert J. Ife,Colin A. Leach,Vahn A. Lewis,Colin H. Macphee,Kevin J. Milliner,Kitty Moores,Ivan L. Pinto,Stephen A. Smith,Ian Stansfield,Steven J. Stanway,Maxine Taylor,Colin J. Theobald	100
10	Mechanismof Action and Antiviral Activity of Benzimidazole-Based AllostericInhibitors of the Hepatitis C Virus RNA-Dependent RNAPolymerase 2003 ·Journal of Virology ·Licia Tomei,Sergio Altamura,Linda Bartholomew,Antonino Biroccio,Alessandra Ceccacci,Laura Pacini,Frank Narjes,Nadia Gennari,Monica Bisbocci,(unknown),Laura Orsatti,(unknown),Ian Stansfield,Michael Rowley,Raffaele De Francesco,Giovanni Migliaccio	160
11	Potent, orally active inhibitors of lipoprotein-associated phospholipase A2: 1-(biphenylmethylamidoalkyl)-pyrimidones 2002 ·Bioorganic & Medicinal Chemistry Letters ·Helen Boyd,(unknown),Deirdre M. B. Hickey,Robert J. Ife,Colin A. Leach,Colin H. Macphee,Kevin J. Milliner,Ivan L. Pinto,(unknown),Stephen A. Smith,Ian Stansfield,Steven J. Stanway,Colin J. Theobald,(unknown)	25
12	Evolution, synthesis and SAR of tripeptide α-ketoacid Inhibitors of the hepatitis C virus NS3/NS4A serine protease 2002 ·Bioorganic & Medicinal Chemistry Letters ·Stefania Colarusso,Benjamin Gerlach,Uwe Koch,Ester Muraglia,Immacolata Conte,Ian Stansfield,Victor G. Matassa,Frank Narjes	40
13	The discovery of SB-435495 2002 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Jackie C. Bloomer,Murray J. B. Brown,Hung‐Yuan Cheng,Richard L. Elliott,Beverley Hammond,Deirdre M. B. Hickey,Robert J. Ife,Colin A. Leach,Vahn A. Lewis,Colin H. Macphee,Kevin J. Milliner,Kitty Moores,Ivan L. Pinto,Stephen A. Smith,Ian Stansfield,Steven J. Stanway,Maxine Taylor,Colin J. Theobald,(unknown)	34
14	The identification of a potent, water soluble inhibitor of lipoprotein-associated phospholipase A2 2001 ·Bioorganic & Medicinal Chemistry Letters ·Helen Boyd,Beverley Hammond,(unknown),Robert J. Ife,Colin A. Leach,Vahn A. Lewis,Colin H. Macphee,Kevin J. Milliner,Ivan L. Pinto,Stephen A. Smith,Ian Stansfield,Colin J. Theobald,(unknown)	8
15	1-(Arylpiperazinylamidoalkyl)-pyrimidones: orally active inhibitors of lipoprotein-associated phospholipase A 2 2001 ·Bioorganic & Medicinal Chemistry Letters ·Jackie C. Bloomer,Helen Boyd,(unknown),Robert J. Ife,Colin A. Leach,Colin H. Macphee,Kevin J. Milliner,Ivan L. Pinto,(unknown),Stephen A. Smith,Ian Stansfield,Steven J. Stanway,Maxine Taylor,Colin J. Theobald,(unknown)	13
16	N-1 substituted pyrimidin-4-ones: novel, orally active inhibitors of lipoprotein-associated phospholipase A2 2000 ·Bioorganic & Medicinal Chemistry Letters ·Helen Boyd,(unknown),(unknown),Deirdre M. B. Hickey,Robert J. Ife,Colin A. Leach,Colin H. Macphee,Kevin J. Milliner,Kitty Moores,Ivan L. Pinto,Rod A. Porter,(unknown),Stephen A. Smith,Ian Stansfield,David G. Tew,Colin J. Theobald,(unknown)	24
17	2-(Alkylthio)pyrimidin-4-ones as novel, reversible inhibitors of lipoprotein-associated phospholipase A2 2000 ·Bioorganic & Medicinal Chemistry Letters ·Helen Boyd,(unknown),(unknown),Robert J. Ife,(unknown),Colin A. Leach,Colin H. Macphee,Kevin J. Milliner,(unknown),Brian P. Slingsby,Stephen A. Smith,Ian Stansfield,David G. Tew,Colin J. Theobald	17
18	ChemInform Abstract: 3′‐(Arylmethyl)‐ and 3′‐(Aryloxy)‐3‐phenyl‐4‐hydroxyquinolin‐2(1H)‐ ones: Orally Active Antagonists of the Glycine Site on the NMDA Receptor. 1994 ·ChemInform ·Janusz J. Kulagowski,R. Baker,Neil R. Curtis,Paul D. Leeson,Ian M. Mawer,Angela M. Moseley,Mark P. Ridgill,Michael Rowley,Ian Stansfield,Alan C. Foster,S. Grimwood,Reginald Hill,J A Kemp,Garland R. Marshall,Kay L. Saywell,Mark D. Tricklebank	11
19	3-Acyl-4-hydroxyquinolin-2(1H)-ones. Systemically active anticonvulsants acting by antagonism at the glycine site of the N-methyl-D-aspartate receptor complex 1993 ·Journal of Medicinal Chemistry ·Michael Rowley,Paul D. Leeson,Graeme I. Stevenson,Angela M. Moseley,Ian Stansfield,Ian R. Sanderson,(unknown),R. BAKER,John A. Kemp	81
20	Synthesis of cis and trans 4-amido 2-carboxytetrahydroquinolines, high affinity ligands at the glycine site of the NMDA receptor 1992 ·Bioorganic & Medicinal Chemistry Letters ·Graeme I. Stevenson,Paul D. Leeson,Michael Rowley,Ian R. Sanderson,Ian Stansfield	14

About Ian Stansfield

Ian Stansfield is a scholar working on Hepatology, Infectious Diseases and Molecular Biology, having authored 23 papers that have together received 745 indexed citations. Recurring topics across this work include Hepatitis C virus research (9 papers), Protein Kinase Regulation and GTPase Signaling (6 papers) and Biochemical and Molecular Research (5 papers). The work is most often cited by research in Hepatology (256 citations), Infectious Diseases (177 citations) and Organic Chemistry (203 citations). Ian Stansfield has collaborated with scholars based in United Kingdom, Italy and United States. Frequent co-authors include Michael Rowley, Frank Narjes, Nadia Gennari, Immacolata Conte, Giovanni Migliaccio, Paul D. Leeson, Graeme I. Stevenson, Uwe Koch, Colin H. Macphee and Kevin J. Milliner. Their work appears in journals such as Journal of Virology, Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact